Givot Yahash: Who Really Controls The Capital Faucet
This follow-up to the main Givot Yahash analysis isolates the governance layer under the financing story. January 2026 gave the board the formal handle over issuance structure and timing, but the supervisor remained embedded in the trustee architecture and operating oversight, and February brought a board entrant tied to an approximately 15% holder.
The main article argued that funding and execution still decide everything at Givot. This follow-up isolates a narrower question sitting underneath every capital raise discussion: who can actually open the capital tap, set the pace of dilution, and decide where the first money goes.
January 2026 pulled that question out into the open. The original meeting notice asked to move the remaining issuance authority approved in June 2024 into the board's hands, so that the board rather than a joint mechanism would decide issuance structure and timing. The amended notice made the fight explicit: alongside the board's proposal, a unit holder added a counterproposal under which any board decision on issuance structure, timing, and the use of the remaining unused capital envelope would only take effect after prior written approval from external director Moshe Polet and supervisor Agadi Torati.
Anyone looking for a simple answer could stop there and say the board won, so the board controls the tap. That is incomplete. The annual report does record that on January 29, 2026 the general meeting adopted the board's proposal and rejected the unit holder's veto proposal. But at Givot, capital control is not measured only by the formal resolution. It also sits in the trustee architecture, in the identity of the people sitting around the board table, and in the fact that the same governance actors also appear in the oversight layer around execution. The board got the formal handle. The plumbing remained multi-layered.
January's Decision: The Handle Moved To The Board
The right place to start is June 2024. That older resolution approved an overall capital raise of up to $10 million, but said that the remaining amount would only be raised through a joint decision of the partnership's CEO, the supervisor, and the external director. In other words, issuance authority was never left with management alone, and it was not left cleanly with the board either.
The January 8, 2026 notice tried to change that. The new proposal said that decisions on issuance structure and issuance timing would be made by the board, not by that earlier three-way mechanism. It is important to notice what the board did not ask for. It did not ask for absolute freedom. In the same wording, the notice said that no actual issuance would be carried out until a drilling-channel agreement had been signed, and that the uses of proceeds would remain as described in the explanatory section.
The January 21 amended notice sharpened the picture further. It added a counterproposal stating that board decisions on issuance structure, timing, and use of the unused capital envelope would only become effective after prior written approval from Moshe Polet and Agadi Torati. At the same time, that amended notice also clarified that even under the board's own proposal no actual issuance would be carried out until both a drilling-channel agreement had been signed and a court decision had been received in the auction process between shareholders of the general partner.
That makes the real issue clear. January was not a fight over whether money had to be raised. It was a fight over who controls the timing of dilution, the shape of the financing package, and the first uses of the proceeds. That is no longer a technical governance footnote. It is control over the partnership's order of priorities.
That chart shows why the control issue matters so much. The January notice said that up to $4.7 million from the capital increase was intended for current expenses and past debts, including about $2.6 million for ongoing expenses through August-September 2026 and about $2.1 million for old debts. So whoever controls the issuance does not merely control future dilution. That actor controls which hole gets funded first, which creditor gets paid first, and how much money remains for the operation itself.
Why The Supervisor Never Really Left The Pipe
This is where the formal reading misses the deeper point. Section 1.4 of the annual report makes clear that the supervisor is not just an outside adviser. Under the trust agreement, he is entitled to appoint the trustee's directors, and he also serves as a director in the trustee company. That is structural, not decorative. The June 2024 wording quoted again in the January notice says that the issuance itself is carried out by the trustee of the participation units. So even after the meeting moved the formal decision on issuance structure and timing to the board, the supervisor remained embedded in the body that actually holds the rights in trust and from which the issuance goes out in practice.
Page 124 of the annual report reinforces that reading from the execution side. It says that appointing a new CEO will only be possible after the necessary financing has been secured and after the employment terms have been approved at the general meeting. In other words, capital authority already shapes the management structure. The same page also says that the operating committee will be set up under Ken Stanley, with Moshe Polet participating as an external-director member and Agadi Torati participating as supervisor-observer.
That is the key point. The same actors who appeared at the center of the January financing dispute also appear in the center of the operating oversight mechanism. At Givot, the capital tap and the execution tap are not separate systems. They sit on the same governance layer.
| Actor | What the filings give them | Why it matters for the capital tap |
|---|---|---|
| General meeting | Changes the capital framework and decides between competing proposals | Even when the board leads, major changes still run through unit holders |
| General partner board | After January 29, decides issuance structure and timing | This is the formal handle on the pace of dilution |
| Supervisor | Appoints trustee directors, serves as a trustee director, and observes the operating committee | He remains inside the architecture holding the units and trust money |
| External director | Was proposed as a prior written approver together with the supervisor and sits in the operating committee | Even without formal veto power, he remains part of the oversight ring |
| General meeting on CEO terms | A new CEO requires both financing and meeting approval of terms | Control over capital also shapes the ability to change management |
That leads to the central conclusion of this follow-up: the unit holder's veto proposal failed, but the supervisor was not really removed from the capital chain. He simply remained in a deeper, more structural, and less visible place within it.
The Board Is No Longer A Neutral Box
If January 2026 reset the formal authority, February 2026 changed the economics of who sits in the room. The director-appointment filing dated March 1, 2026 says that effective February 25, 2026 Dimitri Dovovis was appointed as a regular director. That same filing states explicitly that Mr. Dovovis is the proxy of Ms. Zhanna Tomashevskaya, an interested party holding approximately 15% of the participation units, and that the general meeting of the general partner approved his request to be appointed as a director.
The filing also makes clear what he is not. Dovovis is a regular director, the company does not view him as an independent director, and he is not a member of board committees. In other words, this is not an appointment designed to add a neutral oversight layer. It brings into the boardroom a voice directly tied to a material holder in the units.
That is exactly the moment when the board stops being an administrative box and becomes a capital-allocation arena. Once the general meeting decided that the board would determine issuance structure and timing, the board's own composition became a capital question. If an approximately 15% holder now has representation in the room, every discussion about a raise, its sweetener, its timing, and its first uses also becomes a discussion about the balance of power between holders, management, and gatekeepers.
This is the gap between formal and practical control. Formally, January 2026 strengthened the board. Practically, February 2026 reminded investors that the board is not a neutral equilibrium point. It is the arena itself.
Conclusion
The short answer is that no single person controls Givot's capital faucet. After January 29, 2026 the board holds the formal handle over issuance structure and timing. But this is not clean, isolated control.
The supervisor remains inside the pipe through the trustee company, through the authority to appoint trustee directors, and through his presence in the operating-oversight layer. The external director remains part of that oversight ring. And the board itself changed once a representative tied to a material holder joined it. In practice, the capital faucet at Givot is controlled not by one signature but by a layered system of meeting decisions, board authority, trustee architecture, supervisor influence, and power centers inside the boardroom.
Why does that matter now? Because at Givot, new money is not only growth fuel. It is a prerequisite for appointing a CEO, paying old obligations, funding current expenses, and pushing Meged 6 and Meged 5 into execution. In that kind of structure, whoever holds the capital tap also holds the drilling timetable and the dilution price on the way there.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.